4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-011771
Options or other derivatives
- CEO acquired 0 shares (option exercise)
- CEO acquired 49,067 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pershing Edward CEO | 2026-03-20 | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | D: show line 1 in the form | |||
| Pershing Edward CEO | 2026-03-20 | Option exercise · Series D-1 Convertible Preferred Stock | +49,067 | 2,710,054 | D: show line 2 in the form |
Loading xslF345X06/ownership.xml…